The results of a very promising drug trial by Biogen to treat Alzheimer's disease was presented at the 12th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders in Nice, France today. The conference is meeting March 18-22, 2015. Biogen Idec is the manufacturer of Aducanumab or BIIB037. Neurimmune is the Swiss biotech which originally developed the antibody. The Biogen Phase 1b Trial Participants in the Phase 1b trial were sectioned into five … [Read more...] about Biogen Fastracks New Alzheimer’s Drug